by 
Menstrual cramps are caused due to elevated levels of prostaglandins in the uterus leading to excessive contraction of the uterine muscles. Popular menstrual cramps treatment products include creams, supplements, and painkillers. Creams work by providing heating that relaxes cramped muscles while supplements provide vitamins and herbs that help reduce cramp intensity. Painkillers minimize pain through analgesics. With rising awareness of adverse effects of painkillers, more women are adopting natural remedies like meditation and mindfulness.
The global Menstrual Cramps Treatment Market is estimated to be valued at US$ 652.03 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Key Trends: One of the key trends in the menstrual cramps treatment market is the adoption of meditation and mindfulness practices. Studies have shown mindfulness-based therapies can help reduce discomfort during periods through relaxation of muscles. Mindfulness teaches women to pay attention to bodily sensation in a non-judgmental way which helps in controlling pain perception. It reduces anxiety and stress associated with menstrual cramps. With growing popularity of yoga and meditation globally, more women are incorporating such techniques in their monthly menstrual routine to alleviate cramps naturally without medicines.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the menstrual cramps treatment market is low as it requires large investments in R&D, clinical trials, and manufacturing facilities to develop and commercialize new products.
Bargaining power of buyers: The bargaining power of buyers in the menstrual cramps treatment market is moderate as buyers have several treatment options to choose from for menstrual cramps.
Bargaining power of suppliers: The bargaining power of suppliers in the menstrual cramps treatment market is low due to the presence of multiple raw material suppliers globally.
Threat of new substitutes: The threat of new substitutes in the menstrual cramps treatment market is moderate as other treatment options like painkillers are available.
Competitive rivalry: The competitive rivalry in the menstrual cramps treatment market is high due to the presence of many global as well as regional players offering a variety of products.
Key Takeaways
The global menstrual cramps treatment market is expected to witness high growth over the forecast period 2023-2030.
Regional analysis: North America is expected to dominate the global menstrual cramps treatment market during the forecast period. This is attributed to the rising awareness regarding menstrual health and availability of advanced treatment options in the region. Asia Pacific is expected to witness fastest growth in the market during the forecast period owing to rising healthcare expenditure and increasing adoption of new treatment options in countries like China, India, and Japan.
Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other. Stryker Corporation and Allergan (Abbvie) are amongst the top two players in the market.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
